• Grid View
  • List View
  • Product Image Cognizant HLS Analyst 450x450 - Cognizant’s Strategic Advances in Health Sciences: A Recap of Analyst and Advisor Day

    Cognizant’s Strategic Advances in Health Sciences: A Recap of Analyst and Advisor Day

    The healthcare and life sciences (HLS) sector is undergoing a significant transformation. At the recent Cognizant Analyst and Advisor Day 2024, Cognizant highlighted its strategic advancements in HLS, focusing on patient-centered care, operational efficiency, and technological innovations. Key highlights included AI-driven solutions, such as the Neuro® AI platform, advancements in drug discovery, and models for remote healthcare delivery. Additionally, Cognizant emphasized its partnerships with industry leaders and its commitment to sustainability and scalability. These initiatives position Cognizant as a transformative leader in the HLS sector, driving innovation and improving efficiency in healthcare delivery.

    December, 2024

  • PrimaryImage Life Sciences Digital Services 2022 2023 - Life Sciences Digital Services 2022–2023 RadarView™

    Life Sciences Digital Services 2022–2023 RadarView™

    The Life Sciences Digital Services 2022–2023 RadarView™ can help enterprises craft a robust strategy based on industry outlook, best practices, and digital transformation. The report can also aid in identifying the right partners and service providers to accelerate digital adoption. The 93-page report also identifies key service providers and system integrators that can help enterprises in their digital transformation journeys.

    September, 2022

  • MoneyShot Life Sciences Digital Services 2022–2023 - The Prescription for Life Sciences Is Complicated

    The Prescription for Life Sciences Is Complicated

    With the cost of developing new products rising and regulatory oversight increasing, profit margins are shrinking for life sciences companies. In response, they are investing in digital technologies to reduce costs and shorten development cycles. They are also pursuing acquisitions and investments in specialized companies to strengthen their technological capabilities specifically in the R&D and clinical trials phase of the value chain. As this requires a strong integration of domain and technological expertise, life sciences companies are collaborating with service providers in their digital transformation journey. These emerging trends are covered in Avasant’s Life Sciences Digital Services 2022–2023 RadarView™.

    September, 2022